IperionX Ramps HAMR™ Output to 4.2 Tons, Targets 200 tpa by Year-End

IPXIPX

During Q1 ended March 31, 2026, IperionX transitioned its Virginia titanium powder operations to continuous 24/7 production, ramping HAMR™ output to 4.2 metric tons in March and targeting 200 tpa run-rate by end-CY2026. The company held $48.2M cash plus $42.1M government funding, advancing GenX™ and scaling powder metallurgy capacity.

1. Operations Transition to Continuous Production

In the quarter ended March 31, 2026, IperionX’s Virginia facility moved from commissioning into continuous 24/7 operations, with all HAMR™ powder production systems commissioned and ramping output to approximately 4.2 metric tons in March. GenX™, the next-generation continuous HAMR™ platform, advanced through design and pilot testing, targeting commissioning in mid-2026 to enhance throughput and cost efficiency.

2. Scale-Up of Powder Metallurgy and Additive Manufacturing

Powder metallurgy scale-up progressed with optimization of a 100-ton uniaxial press, commissioning of a cold isostatic press, and installation of a six-axis 300-ton SACMI powder metallurgy press slated for June-quarter commissioning. Additional HSPT™ sintering furnaces and expanded binder jet additive systems are set to alleviate sintering bottlenecks and support higher-rate production of complex titanium components.

3. Customer and Government Engagement

Prototype production, qualification testing, and low-rate initial production ramped across defense, automotive, consumer electronics, and industrial applications under a tiered go-to-market strategy prioritizing high-value engineered products. U.S. Government support included full obligation of a $47.1M IBAS award, transfer of ~290 metric tons of titanium scrap feedstock, and an SBIR Phase III IDIQ contract valued up to $99M.

4. Financial Position and Outlook

IperionX closed the quarter with $48.2M in cash and $42.1M of remaining obligated U.S. Government funding pending reimbursement. Based on current operating plans, capital expenditure, and reimbursement timing, year-end FY2026 cash is projected between $36M and $40M.

Sources

F